Advanced Obesity Drug 9604 (AOD-9604) is a synthetic peptide fragment corresponding to the C-terminus region (amino acids 177–191) of human growth hormone, stabilized with a terminal disulfide bond. It is studied to evaluate isolated beta-3 adrenergic receptor activity and lipolytic enzyme synthesis without influencing systemic insulin resistance or cellular proliferation.
